ArticleActa psychiatrica Scandinavica2026
Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects.
Article in Acta psychiatrica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Concomitant pathologies and their impact on schizophrenia: a narrative overview of current evidence.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects.Acta psychiatrica Scandinavica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMajor psychiatric disorder, including schizophrenia, bipolar disorder, and major depressive disorder, has been individually associated with increased risk of stroke. However, few studies have directly compared the stroke risk across these diagnostic groups within a unified cohort framework while accounting for stroke subtypes and relevant confounders.
methodsUsing Taiwan's National Health Insurance Research Database, we identified 30,945 patients with schizophrenia, 30,360 with bipolar disorder, 30,447 with major depressive disorder, and 91,752 age-matched controls without psychiatric illness between 2001 and 2009. Participants were followed until death or the end of 2011. Cox regression models were used to estimate the hazard ratio (HR) for ischemic and hemorrhagic stroke, adjusting for potential confounding factors. Sensitivity analyses were conducted by excluding stroke events occurring within the first 1 or 3 years of psychiatric diagnosis.
resultsAll three psychiatric groups exhibited significantly higher risks of ischemic and hemorrhagic stroke compared with controls. Stroke risk remained consistently elevated across age and sex strata for all psychiatric groups. Greater cumulative exposure to antidepressants was associated with reduced stroke risk across all three disorders; antipsychotics showed protective associations in schizophrenia and bipolar disorder, non-lithium mood stabilizers were protective only in bipolar disorder, and lithium showed no significant association with stroke risk.
conclusionSchizophrenia, bipolar disorder, and major depressive disorder are independently associated with increased stroke risk. These findings highlight the need for integrated vascular risk monitoring in psychiatric care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.